CD4 depletion or CD40L blockade results in antigen-specific tolerance in a red blood cell alloimmunization model

Frontiers in Immunology

Volumn 8, Issue AUG, 2017, Pages

  Natarajan, Prabitha ^a   Liu, Dong ^a   Patel, Seema R ^b   Santhanakrishnan, Manjula ^a   Beitler, Daniel ^a   Liu, Jingchun ^a   Gibb, David R ^a   Liepkalns, Justine S ^b   Madrid, David J ^a   Eisenbarth, Stephanie C ^a   Stowell, Sean R ^b   Hendrickson, Jeanne E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunization; CD40L blockade; Red blood cell; T cells; Tolerance

Indexed keywords

CD40 LIGAND; FLUORESCENT DYE; GLYCOPHORIN A;

ADOPTIVE TRANSFER; ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IMMUNE CELL SUB POPULATION ANALYSIS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL PARAMETERS; MOUSE; NONHUMAN; SPLEEN TISSUE;

EID: 85027132614     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00907     Document Type: Article

References (60)

1. 2009 National Blood Collection and Utilization Survey Report. US Department of Health and Human Services (2011). Available from: http://www.hhs.gov/ash/bloodsafety/nbcus/index.html
2. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg (2009) 108:759-69. doi:10.1213/ane.0b013e3181930a6e
3. Savage WJ. Transfusion reactions. Hematol Oncol Clin North Am (2016) 30:619-34. doi:10.1016/j.hoc.2016.01.012
4. Reid M, Lomas-Francis C. The Blood Group Antigen Facts Book. Amsterdam: Elsevier Academic Press (2004)
5. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol (2004) 41:93-117. doi:10.1053/j.seminhematol.2004.01.001
6. Hendrickson JE, Tormey CA. Red blood cell antibodies in hematology/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies. Hematol Oncol Clin North Am (2016) 30:635-51. doi:10.1016/j.hoc.2016.01.006
7. Fasano RM, Booth GS, Miles M, Du L, Koyama T, Meier ER, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol (2015) 168:291-300. doi:10.1111/bjh.13123
8. Ryder AB, Hendrickson JE, Tormey CA. Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization. Br J Haematol (2016) 174:483-5. doi:10.1111/bjh.13781
9. Fatalities Reported to the FDA Following Blood Collection. US Department of Health and Human Services (FDA) (2014). Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability
10. Nickel RS, Hendrickson JE, Fasano RM, Meyer EK, Winkler AM, Yee MM, et al. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion (2016) 56:107-14. doi:10.1111/trf.13379
11. Gardner K, Hoppe C, Mijovic A, Thein SL. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease. Br J Haematol (2015) 170:745-56. doi:10.1111/bjh.13494
12. Calabro S, Gallman A, Gowthaman U, Liu D, Chen P, Liu J, et al. Bridging channel dendritic cells induce immunity to transfused red blood cells. J Exp Med (2016) 213:887-96. doi:10.1084/jem.20151720
13. Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev (2016) 30:159-64. doi:10.1016/j.tmrv.2016.05.008
14. Webb J, Abraham A. Complex transfusion issues in pediatric hematopoietic stem cell transplantation. Transfus Med Rev (2016) 30:202-8. doi:10.1016/j.tmrv.2016.06.002
15. Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion (2007) 47:28-40. doi:10.1111/j.1537-2995.2007.01060.x
16. Rourk A, Squires JE. Implications of the Kidd blood group system in renal transplantation. Immunohematology (2012) 28:90-4
17. Chou ST, Fasano RM. Management of patients with sickle cell disease using transfusion therapy: guidelines and complications. Hematol Oncol Clin North Am (2016) 30:591-608. doi:10.1016/j.hoc.2016.01.011
18. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood (2013) 122:1062-71. doi:10.1182/blood-2013-03-490623
19. Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev (2016) 30:197-201. doi:10.1016/j.tmrv.2016.05.011
20. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med (2005) 129:190-3
21. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, et al. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion (2014) 54:2034-44. doi:10.1111/trf.12585
22. Ryder AB, Zimring JC, Hendrickson JE. Factors influencing RBC alloimmunization: lessons learned from murine models. Transfus Med Hemother (2014) 41:406-19. doi:10.1159/000368995
23. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion (2006) 46:1328-33. doi:10.1111/j.1537-2995.2006.00900.x
24. Auffray I, Marfatia S, De Jong K, Lee G, Huang CH, Paszty C, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood (2001) 97:2872-8. doi:10.1182/blood.V97.9.2872
25. Yu J, Heck S, Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol (2007) 82:691-6. doi:10.1002/ajh.20959
26. Smith NH, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood (2012) 119:1566-9. doi:10.1182/blood-2011-09-382655
27. Gibb DR, Liu J, Natarajan P, Santhanakrishnan M, Madrid DJ, Eisenbarth SC, et al. Type I IFN is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice. J Immunol (2017). doi:10.4049/jimmunol.1700401
28. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood (2009) 114:2315-22. doi:10.1182/blood-2009-04-214387
29. Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, et al. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion (2012) 52:2620-30. doi:10.1111/j.1537-2995.2012.03641.x
30. Gilson CR, Zimring JC. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model. Transfusion (2012) 52:849-59. doi:10.1111/j.1537-2995.2011.03346.x
31. Ferrer IR, Liu D, Pinelli DF, Koehn BH, Stempora LL, Ford ML. CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules. J Immunol (2012) 189:4387-95. doi:10.4049/jimmunol.1201757
32. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion (2012) 52:2631-45. doi:10.1111/j.1537-2995.2012.03647.x
33. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion (2006) 46:1526-36. doi:10.1111/j.1537-2995.2006.00946.x
34. Takemori T, Kaji T, Takahashi Y, Shimoda M, Rajewsky K. Generation of memory B cells inside and outside germinal centers. Eur J Immunol (2014) 44:1258-64. doi:10.1002/eji.201343716
35. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med (1996) 184:747-52. doi:10.1084/jem.184.2.747
36. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, et al. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol (1994) 152:5643-52
37. Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev (2009) 229:152-72. doi:10.1111/j.1600-065X.2009.00782.x
38. Arneja A, Salazar JE, Jiang W, Hendrickson JE, Zimring JC, Luckey CJ. Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica (2016) 101:e440-4. doi:10.3324/haematol.2016.149278
39. Vogel I, Verbinnen B, Van Gool S, Ceuppens JL. Regulatory T cell-dependent and-independent mechanisms of immune suppression by CD28/B7 and CD40/CD40L costimulation blockade. J Immunol (2016) 197:533-40. doi:10.4049/jimmunol.1502039
40. Evers D, Van Der Bom JG, Tijmensen J, Middelburg RA, De Haas M, Zalpuri S, et al. Red cell alloimmunisation in patients with different types of infections. Br J Haematol (2016) 175:956-66. doi:10.1111/bjh.14307
41. Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation (1996) 61:4-9. doi:10.1097/00007890-199601150-00002
42. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med (1999) 5:686-93. doi:10.1038/9536
43. Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance. Thromb Haemost (2001) 86:1345-52
44. Cremel M, Guerin N, Horand F, Banz A, Godfrin Y. Red blood cells as innovative antigen carrier to induce specific immune tolerance. Int J Pharm (2013) 443:39-49. doi:10.1016/j.ijpharm.2012.12.044
45. Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang (1990) 58:50-5. doi:10.1111/j.1423-0410.1990.tb02055.x
46. Tatari-Calderone Z, Minniti CP, Kratovil T, Stojakovic M, Vollmer A, Barjaktarevic I, et al. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Mol Immunol (2009) 47:64-70. doi:10.1016/j.molimm.2008.12.027
47. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, et al. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion (2014) 54:972-81; quiz 971. doi:10.1111/trf.12348
48. Kontos S, Kourtis IC, Dane KY, Hubbell JA. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A (2013) 110:E60-8. doi:10.1073/pnas.1216353110
49. Grimm AJ, Kontos S, Diaceri G, Quaglia-Thermes X, Hubbell JA. Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Sci Rep (2015) 5:15907. doi:10.1038/srep15907
50. Lorentz KM, Kontos S, Diaceri G, Henry H, Hubbell JA. Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase. Sci Adv (2015) 1:e1500112. doi:10.1126/sciadv.1500112
51. Bao W, Yu J, Heck S, Yazdanbakhsh K. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood (2009) 113:5624-7. doi:10.1182/blood-2008-12-193748
52. Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S, et al. Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol (2011) 86:1001-6. doi:10.1002/ajh.22167
53. Verbinnen B, Billiau AD, Vermeiren J, Galicia G, Bullens DM, Boon L, et al. Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol (2008) 181:1034-42. doi:10.4049/jimmunol.181.2.1034
54. Marigo I, Zilio S, Desantis G, Mlecnik B, Agnellini AH, Ugel S, et al. T cell cancer therapy requires CD40-CD40L activation of tumor necrosis factor and inducible nitric-oxide-synthase-producing dendritic cells. Cancer Cell (2016) 30:377-90. doi:10.1016/j.ccell.2016.08.004
55. Baumjohann D, Preite S, Reboldi A, Ronchi F, Ansel KM, Lanzavecchia A, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity (2013) 38:596-605. doi:10.1016/j.immuni.2012.11.020
56. Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A, et al. Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol (2017) 198:2671-80
57. Arthur CM, Patel SR, Sullivan HC, Winkler AM, Tormey CA, Hendrickson JE, et al. CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood (2016) 127:1823-7. doi:10.1182/blood-2015-10-673426
58. Patel CC Sr, Medford A, Zimring JC. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest (2009) 119:2787-94. doi:10.1172/JCI39590
59. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 6:114. doi:10.1038/72162
60. Pinelli DF, Ford ML. Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance. Immunotherapy (2015) 7:399-410. doi:10.2217/imt.15.1